Pfiz­er in­vests $25M in­to Cari­bou Bio­sciences, gets first dibs on off-the-shelf CAR-T ther­a­py for mul­ti­ple myelo­ma

Pfiz­er bought $25 mil­lion in shares of Cari­bou Bio­sciences, a Jen­nifer Doud­na-found­ed biotech that us­es CRISPR edit­ing to cre­ate off-the-shelf cell ther­a­pies.

In ex­change, Pfiz­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER